We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
The retina sub-specialism is a branch of ophthalmology concerned with studying, diagnosing and treating retina, uvea and vitreous conditions.
Among the pathologies tackled by this sub-specialism are pathologies of the retina that require medical treatment, including: diabetic retinopathy, retinal vascular disorder, such as venous thrombosis or arterial occlusions, age-associated macular degeneration or severe myopia.
The Department has the most advanced technology for the surgical treatment of various retina conditions:
The Department also has the technology required for correct differential diagnosis of tumour pathologies of the eye and to conduct multi-disciplinary exams to diagnose and monitor patients. With regard to treating choroidal melanoma, the Department performs treatment through vitrectomy, acquiring tumour samples, and through tumour endoresection, as well as plaque brachytherapy implant (local radiotherapy).
The Retina Department at Vall d'Hebron Hospital constantly works on implementing and updating protocols of action on the different diseases of the retina and vitreous. The Retina Department is highly committed to research and teaching. It stands out for its long tradition of publications and for publishing chapters in books, as well as for taking part in various national and international studies on the latest scientific advances and technological innovation, allowing us to offer our patients the latest therapeutic advances.
The clinical and basic research activity of the ophthalmology research group focuses on finding new treatments for blindness. We have a research programme in developing new therapeutic strategies based on: a) gene and cell therapies to regenerate or halt the retina degeneration process in pre-clinical models; b) eyewash formulae to discover new anti-inflammatory and anti-oxidant compounds to treat retina conditions; and c) 3D retinal organoids derived from hiPSC and bioscaffolds used as models of retinal disease, both for genome editing and drug screening.
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.